CN106074923A - The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method - Google Patents

The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method Download PDF

Info

Publication number
CN106074923A
CN106074923A CN201610265736.0A CN201610265736A CN106074923A CN 106074923 A CN106074923 A CN 106074923A CN 201610265736 A CN201610265736 A CN 201610265736A CN 106074923 A CN106074923 A CN 106074923A
Authority
CN
China
Prior art keywords
rhizoma
accounts
arthritis
shide
myth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610265736.0A
Other languages
Chinese (zh)
Inventor
陈堃
陈人智
陈卫川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610265736.0A priority Critical patent/CN106074923A/en
Publication of CN106074923A publication Critical patent/CN106074923A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • A61K36/126Drynaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237Notopterygium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487Psoralea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Abstract

The invention discloses pharmaceutical formulation and the manufacture method of a kind for the treatment of of arthritis, by spreading French Franc, shide, leaf in wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall loses, Fructus Psoraleae Rhizoma Drynariae, answer must in myth sue for peace Rhizoma Homalomenae composition, compared with prior art, the present invention uses multiple Huis incense drug secret, it is evident in efficacy, effect is unique, easy to use, there is expelling wind and cold, removing obstruction from collaterals, promoting blood circulation and detumescence, improve immunity, the pharmacological action of strengthening vital QI to eliminate pathogenic factors, it is widely used in anemofrigid-damp arthralgia, limbs pain, numb limbs and tense tendons, acute soft tissue injury, scapulohumeral periarthritis, cervical spondylosis, osteoarthritis, the diseases such as neuralgia.

Description

The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method
Technical field
The present invention relates to a kind of pharmaceutical formulation, particularly relate to pharmaceutical formulation and the manufacture method of a kind for the treatment of of arthritis.
Background technology
Osteoarthritis is a kind of degeneration, is owing to increasing age, obesity, strain, wound, joint birth defect, pass Articular cartilage degeneration damage, joint margins and the subchondral bone reactive hyperplasia that the factors such as joint deformity cause, closes also known as bone Joint disease, degenerative osteoarthritis, senile arthritis, hypertrophiarthritis etc..Clinical manifestation is arthralgia, the pressure slowly developed Bitterly, stiff, arthroncus, limitation of activity and joint deformity etc..Curative effect of medication of the prior art is not the most notable, accordingly, it would be desirable to Update.
Summary of the invention
The purpose of the present invention is that pharmaceutical formulation and the system providing a kind for the treatment of of arthritis in order to solve the problems referred to above Make method.
The present invention is achieved through the following technical solutions above-mentioned purpose:
The present invention by spread leaf in French Franc, shide, wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth sue for peace Rhizoma Homalomenae forms, described in spread that French Franc accounts for 10%, described shide accounts for 10%, leaf accounts for 15% in described wood, described Rhizoma Et Radix Notopterygii accounts for 10%, institute State Radix Angelicae Pubescentis account for 20%, described wall lose account for 15%, described Fructus Psoraleae Rhizoma Drynariae accounts for 20%, described in answer must in myth beg account for 5%, described Rhizoma Homalomenae accounts for 5%.
The manufacture method of the present invention comprises the following steps:
(1) take qualified spread leaf in French Franc, shide, wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth Rhizoma Homalomenae of suing for peace reaches, through pulverizing, the powder that mesh number is 120 mesh;
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops To 70-80 spend time, slowly add the crude drug in whole that step (1) weighs and stir, with the length of side be 10 × 12cm centimetre just The mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre is wrapped up in square patch.
The beneficial effects of the present invention is:
The present invention is pharmaceutical formulation and the manufacture method of a kind for the treatment of of arthritis, and compared with prior art, the present invention uses Multiple Huis incense drug secret, it is evident in efficacy, effect is unique, easy to use, have expelling wind and cold, removing obstruction from collaterals, promoting blood circulation and detumescence, Improving immunity, the pharmacological action of strengthening vital QI to eliminate pathogenic factors, be widely used in anemofrigid-damp arthralgia, limbs pain, numb limbs and tense tendons, acute soft tissue damages Wound, the disease such as scapulohumeral periarthritis, cervical spondylosis, osteoarthritis, neuralgia.
Detailed description of the invention
The invention will be further described below:
The present invention by spread leaf in French Franc, shide, wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth sue for peace Rhizoma Homalomenae forms, described in spread that French Franc accounts for 10%, described shide accounts for 10%, leaf accounts for 15% in described wood, described Rhizoma Et Radix Notopterygii accounts for 10%, institute State Radix Angelicae Pubescentis account for 20%, described wall lose account for 15%, described Fructus Psoraleae Rhizoma Drynariae accounts for 20%, described in answer must in myth beg account for 5%, described Rhizoma Homalomenae accounts for 5%.
The manufacture method of the present invention comprises the following steps:
(1) take qualified spread leaf in French Franc, shide, wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth Rhizoma Homalomenae of suing for peace reaches, through pulverizing, the powder that mesh number is 120 mesh;
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops To 70-80 spend time, slowly add the crude drug in whole that step (1) weighs and stir, with the length of side be 10 × 12cm centimetre just The mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre is wrapped up in square patch.
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The technology of the industry Personnel, it should be appreciated that the present invention is not restricted to the described embodiments, simply illustrating this described in above-described embodiment and description The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, and these become Change and improvement both falls within scope of the claimed invention.Claimed scope by appending claims and Equivalent defines.

Claims (2)

1. the pharmaceutical formulation of a treatment of arthritis, it is characterised in that: by spreading leaf, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall in French Franc, shide, wood Mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth sue for peace Rhizoma Homalomenae composition, described in spread that French Franc accounts for 10%, described shide accounts for 10%, described In wood, leaf accounts for 15%, described Rhizoma Et Radix Notopterygii accounts for 10%, described Radix Angelicae Pubescentis accounts for 20%, described wall lose account for 15%, described Fructus Psoraleae Rhizoma Drynariae accounts for 20%, answer described in must in myth beg account for 5%, described Rhizoma Homalomenae accounts for 5%.
The production method of medicament for the treatment of of arthritis the most according to claim 1, it is characterised in that comprise the following steps:
(1) take qualified spread leaf in French Franc, shide, wood, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, wall mistake, Fructus Psoraleae Rhizoma Drynariae, answer must in myth sue for peace Rhizoma Homalomenae reaches, through pulverizing, the powder that mesh number is 120 mesh;
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops to 70- When 80 degree, slowly add the crude drug in whole that step (1) weighs and stir, by the positive square patch that the length of side is 10 × 12cm centimetre Cloth wraps up the mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre.
CN201610265736.0A 2016-04-26 2016-04-26 The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method Pending CN106074923A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610265736.0A CN106074923A (en) 2016-04-26 2016-04-26 The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610265736.0A CN106074923A (en) 2016-04-26 2016-04-26 The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method

Publications (1)

Publication Number Publication Date
CN106074923A true CN106074923A (en) 2016-11-09

Family

ID=58702364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610265736.0A Pending CN106074923A (en) 2016-04-26 2016-04-26 The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method

Country Status (1)

Country Link
CN (1) CN106074923A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107224549A (en) * 2017-06-08 2017-10-03 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 A kind of rhinitis rinses pharmaceutical formulation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1118285C (en) * 2000-08-28 2003-08-20 赵芳可 Shubi plaster for treating arthralgia due to wind-cold-dampness
CN101274067A (en) * 2007-03-26 2008-10-01 郭茂武 Medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain, and method for preparing the same
CN102614389A (en) * 2012-04-25 2012-08-01 巩凤英 Chinese medicinal patch
CN103127326A (en) * 2011-11-22 2013-06-05 周昌明 Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN104436103A (en) * 2014-11-06 2015-03-25 王全文 External rheumatalgia-relieving bone penetrating plaster and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1118285C (en) * 2000-08-28 2003-08-20 赵芳可 Shubi plaster for treating arthralgia due to wind-cold-dampness
CN101274067A (en) * 2007-03-26 2008-10-01 郭茂武 Medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain, and method for preparing the same
CN103127326A (en) * 2011-11-22 2013-06-05 周昌明 Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN102614389A (en) * 2012-04-25 2012-08-01 巩凤英 Chinese medicinal patch
CN104436103A (en) * 2014-11-06 2015-03-25 王全文 External rheumatalgia-relieving bone penetrating plaster and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
周德生等: "《简明中药手册》", 31 January 2014, 山西科学技术出版社 *
惠宏等: "《《回回药方》校笺》", 31 December 2013, 阳光出版社 *
牛阳: "《中国回药志》", 31 December 2015, 阳光出版社 *
贾孟辉: "《《回回药方》残本注评》", 31 March 2015, 阳光出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107224549A (en) * 2017-06-08 2017-10-03 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 A kind of rhinitis rinses pharmaceutical formulation

Similar Documents

Publication Publication Date Title
CN104435926A (en) Chinese patent medicine for rheumatism
CN103933129B (en) Plaster for treating pain
CN106074923A (en) The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method
CN103230487A (en) Plaster for bone disease treatment
CN102755597B (en) Chinese medicine for treating acute soft tissue injury
CN104162114B (en) Traditional Chinese medicine composition for treating wind-cold obstruction type cervical spondylotic radiculopathy
CN103623160B (en) A kind of promoting blood circulation to remove obstruction in the collateral dispersing cold for relieving pain pastes and preparation method thereof
CN104189345A (en) Externally applied traditional Chinese medicine plaster for treating aching diseases
CN106581241A (en) Burn and scald treating traditional Chinese medicine composition
CN104873615A (en) Cinnamon oil containing externally applied medicine for treating traumatic injury
CN103977334A (en) Plaster for treating cervical spondylosis, lumbar spondylosis and various arthritis
CN104474100A (en) Traditional Chinese medicine for setting of fracture
CN103800506B (en) A kind of Chinese medicine composition treating infantile parotitis and preparation method thereof
CN101695559A (en) Ointment for treating osteoarthropathy and preparation method thereof
CN108114118A (en) A kind of acupoint plaster for treating antimigraine
CN106074988A (en) A kind of externally-used pain-relieving medical ointment prescription and manufacture method
CN105878497A (en) Medicinal moxa stick capable of treating insomnia
CN107441318A (en) A kind of Chinese medicine composition for treating insomnia
CN102343069B (en) Traditional Chinese medicine liquor for treating rheumatism and manufacturing method thereof
CN104324170A (en) Radix clematidis-garden balsam stem powder and preparation method thereof
CN103566272B (en) A kind of Chinese medicine for the treatment of hyperosteogeny
CN104721327A (en) Traditional Chinese medicine externally applied medicine used for treating paronychia
CN110269919A (en) Chinese medicine composition and its application, the strong precious jade ironing pack comprising Chinese medicine composition and application method
CN110613831A (en) Miao medicine rehabilitation external-use medicinal egg and preparation method thereof
CN106177330A (en) A kind of oral and external applied medicine treating the arthroncus of knee

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20161109